Kangstem Biotech Co. Ltd Cash Flow Reinvestment Rate
Latest as of June 2019:
6.10x
Kangstem Biotech Co. Ltd cash flow reinvestment rate. Kangstem Biotech Co. Ltd (217730) has a Cash Flow Reinvestment Rate of 6.10x as of June 2019, reinvesting ₩6.86 Billion (capex ₩1.18 Billion plus investments ₩5.68 Billion) from operating cash flow of ₩1.12 Billion. Explore Kangstem Biotech Co. Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
6.10x
(Capex + Investments) / Operating CF
Total Reinvested
₩6.86 Billion
Capex + Investments
Operating Cash Flow
₩1.12 Billion
KRW
Capital Expenditures
₩1.18 Billion
KRW
Kangstem Biotech Co. Ltd Cash Flow Reinvestment Rate by Year (None–None)
Kangstem Biotech Co. Ltd cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Kangstem Biotech Co. Ltd. For the full cash flow conversion analysis, see 217730 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow